PMID- 19164851 OWN - NLM STAT- MEDLINE DCOM- 20090414 LR - 20200319 IS - 0922-6028 (Print) IS - 0922-6028 (Linking) VI - 27 IP - 1 DP - 2009 TI - Different postischemic protein expression of the GABA(A) receptor alpha2 subunit and the plasticity-associated protein MAP1B after treatment with BDNF versus G-CSF in the rat brain. PG - 27-39 LID - 10.3233/RNN-2009-0459 [doi] AB - PURPOSE: Recent data indicate that both brain-derived neurotrophic factor (BDNF) and granulocyte-colony stimulating factor (G-CSF) exert substantial neuroregenerative effects and improve functional outcome after ischemic stroke. In the present study, we checked for potential differences in the postischemic modulation of various excitatory and inhibitory neurotransmitter receptors as well as various marker molecules for structural plasticity by BDNF versus G-CSF. METHODS: Adult male Wistar rats were subjected to photothrombotic ischemia and subsequently treated with NaCl, BDNF or G-CSF, respectively. After 6 weeks, postischemic protein expression of the NR1, GluR1 and alpha2 subunit of the NMDA, AMPA and GABA(A) receptor, respectively, was semiquantitatively determined ipsi- and contralateral to the ischemic lesion. Structural plasticity was further analyzed immunohistochemically using antibodies against MAP1B, MAP2 and synaptophysin. RESULTS: Only BNDF caused a significantly reduced postischemic protein expression of the GABA(A) receptor alpha2 subunit and the NR1 subunit of the NMDA receptor in the hippocampus. Furthermore, BDNF compared to G-CSF increased MAP1B protein expression in the periischemic regenerative region. CONCLUSIONS: Although both BDNF and G-CSF have been shown to improve postischemic functional outcome to a similar extent, exogenous administration results in different underlying structural reorganization processes suggesting specific modulations of plasticity-associated events by these trophic factors. FAU - Muller, Harald D AU - Muller HD AD - Division of Neuropathology, Bezirkskrankenhaus Gunzburg, Gunzburg, Germany. FAU - Neder, Angelika AU - Neder A FAU - Sommer, Clemens AU - Sommer C FAU - Schabitz, Wolf-Rudiger AU - Schabitz WR LA - eng PT - Comparative Study PT - Journal Article PL - Netherlands TA - Restor Neurol Neurosci JT - Restorative neurology and neuroscience JID - 9005499 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Gabra2 protein, rat) RN - 0 (MAP2 protein, rat) RN - 0 (Microtubule-Associated Proteins) RN - 0 (Receptors, GABA-A) RN - 0 (Synaptophysin) RN - 0 (microtubule-associated protein 1B) RN - 143011-72-7 (Granulocyte Colony-Stimulating Factor) SB - IM MH - Analysis of Variance MH - Animals MH - Brain/*drug effects/metabolism MH - Brain-Derived Neurotrophic Factor/*pharmacology/therapeutic use MH - Disease Models, Animal MH - Functional Laterality MH - Gene Expression Regulation/*drug effects MH - Granulocyte Colony-Stimulating Factor/*pharmacology/therapeutic use MH - Intracranial Thrombosis/complications MH - Male MH - Microtubule-Associated Proteins/*metabolism MH - Random Allocation MH - Rats MH - Rats, Wistar MH - Receptors, GABA-A/*metabolism MH - Stroke/drug therapy/etiology/*pathology/physiopathology MH - Synaptophysin/metabolism EDAT- 2009/01/24 09:00 MHDA- 2009/04/15 09:00 CRDT- 2009/01/24 09:00 PHST- 2009/01/24 09:00 [entrez] PHST- 2009/01/24 09:00 [pubmed] PHST- 2009/04/15 09:00 [medline] AID - 01544415727L23G5 [pii] AID - 10.3233/RNN-2009-0459 [doi] PST - ppublish SO - Restor Neurol Neurosci. 2009;27(1):27-39. doi: 10.3233/RNN-2009-0459.